TapewireFind a company

person · Reporting owner

Maheshwari Anshul

Disclosed activity across 1 company

Tapewire entity
19532
SEC CIK
0001853089

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
SI-BONE, Inc.SIBN · Entity 2501Chief Op & Financial OfficerOctober 02, 2026October 06, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

SI-BONE, Inc.

Report date October 02, 2026 · Filed October 06, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect221,724 Reported balance After 2026-10-02 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2026-10-02 · Sale · Disposed 1,560 · Balance 221,724

F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2: This transaction was executed in multiple trades at prices ranging from $18.05 USD to $18.45 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Common StockSEC Table I · non-derivativeDirect219,966 Reported balance After 2026-10-02 transaction · row 2 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 2 · 2026-10-02 · Sale · Disposed 1,758 · Balance 219,966

F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2: This transaction was executed in multiple trades at prices ranging from $18.05 USD to $18.45 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Common StockSEC Table I · non-derivativeDirect218,235 Reported balance After 2026-10-05 transaction · row 3 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 3 · 2026-10-05 · Sale · Disposed 1,731 · Balance 218,235

F3: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 17, 2025.

F4: Includes 160,823 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Filing footnotes · ownership attribution and instrument terms

F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2: This transaction was executed in multiple trades at prices ranging from $18.05 USD to $18.45 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 17, 2025.

F4: Includes 160,823 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
April 02, 2025 Filed Apr 4, 2025 21:12 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,754 $14.14 $24,793.14
Disclosure

SEC source: 0001562180-25-003005 · primarydocument.xml · nonDerivative · entry 2

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 270,293

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $13.78 USD to $14.37 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 · balance_after: Includes 180,329 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
April 02, 2025 Filed Apr 4, 2025 21:12 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,557 $14.09 $21,930.35
Disclosure

SEC source: 0001562180-25-003005 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,047

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $13.78 USD to $14.32 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 21:18 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,167 $16.74 $19,530.45
Disclosure

SEC source: 0001562180-25-001487 · primarydocument.xml · nonDerivative · entry 7

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 273,604

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F7 · price: This transaction was executed in multiple trades at prices ranging from $16.21 USD to $16.94 USD; the price reported above reflects the weighted average sale price.

F8 · balance_after: Includes 187,109 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 21:18 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 524 $17.35 $9,089.09
Disclosure

SEC source: 0001562180-25-001487 · primarydocument.xml · nonDerivative · entry 6

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 274,771

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $17.29 USD to $17.40 USD; the price reported above reflects the weighted average sale price.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 21:18 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 3,782 $16.94 $64,070.86
Disclosure

SEC source: 0001562180-25-001487 · primarydocument.xml · nonDerivative · entry 5

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 275,295

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F6 · price: This transaction was executed in multiple trades at prices ranging from $16.285 USD to $17.28 USD; the price reported above reflects the weighted average sale price.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 21:18 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 2,971 $16.86 $50,085.71
Disclosure

SEC source: 0001562180-25-001487 · primarydocument.xml · nonDerivative · entry 4

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 279,077

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F5 · price: This transaction was executed in multiple trades at prices ranging from $16.285 USD to $17.26 USD; the price reported above reflects the weighted average sale price.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 21:18 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,276 $16.66 $21,254.97
Disclosure

SEC source: 0001562180-25-001487 · primarydocument.xml · nonDerivative · entry 3

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 282,048

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F4 · price: This transaction was executed in multiple trades at prices ranging from $16.17 USD to $16.93 USD; the price reported above reflects the weighted average sale price.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 21:18 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 156 $17.36 $2,708.38
Disclosure

SEC source: 0001562180-25-001487 · primarydocument.xml · nonDerivative · entry 2

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 283,324

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $17.29 USD to $17.40 USD; the price reported above reflects the weighted average sale price.

Read SEC document
February 18, 2025 Filed Feb 21, 2025 21:18 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,304 $16.70 $21,778.76
Disclosure

SEC source: 0001562180-25-001487 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 283,480

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $16.22 USD to $16.92 USD; the price reported above reflects the weighted average sale price.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 23:09 UTC SI-BONE, Inc. SIBN · Entity 2501 GrantCommon Stock 23,866 $0.00 $0.00
Disclosure

SEC source: 0001562180-25-000980 · primarydocument.xml · nonDerivative · entry 2

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 284,784

F2 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest, if at all, over three years based on the Issuer's total shareholder return (TSR) as measured against the TSR of the company at the median of the range TSRs of a set of peer companies established by the Issuer as set forth in the grant.

F3 · balance_after: Includes 210,079 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 03, 2025 Filed Feb 5, 2025 23:09 UTC SI-BONE, Inc. SIBN · Entity 2501 GrantCommon Stock 71,599 $0.00 $0.00
Disclosure

SEC source: 0001562180-25-000980 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 260,918

F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest over four years beginning on February 15, 2025, and will be released in quarterly installments, subject to the Reporting Person's continued service through each relevant vesting date.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 23:56 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,726 $13.91 $24,007.45
Disclosure

SEC source: 0001562180-25-000214 · primarydocument.xml · nonDerivative · entry 3

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 189,319

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F4 · price: This transaction was executed in multiple trades at prices ranging from $13.65 USD to $14.36 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5 · balance_after: Includes 114,614 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 23:56 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,944 $13.93 $27,085.75
Disclosure

SEC source: 0001562180-25-000214 · primarydocument.xml · nonDerivative · entry 2

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,045

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $13.66 USD to $14.32 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 23:56 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,634 $13.90 $22,708.84
Disclosure

SEC source: 0001562180-25-000214 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192,989

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $13.66 USD to $14.355 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 18, 2024 Filed Nov 20, 2024 22:11 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,274 $12.67 $16,138.65
Disclosure

SEC source: 0001562180-24-007839 · primarydocument.xml · nonDerivative · entry 2

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,623

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $12.41 USD to $13.025 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 · balance_after: Includes 124,413 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
November 18, 2024 Filed Nov 20, 2024 22:11 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,165 $12.70 $14,797.95
Disclosure

SEC source: 0001562180-24-007839 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 195,897

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $12.43 USD to $13.04 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 02, 2024 Filed Oct 4, 2024 22:54 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,751 $13.59 $23,795.74
Disclosure

SEC source: 0001562180-24-007249 · primarydocument.xml · nonDerivative · entry 2

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 197,062

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $13.35 USD to $13.70 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes 129,416 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
October 02, 2024 Filed Oct 4, 2024 22:54 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,554 $13.57 $21,090.58
Disclosure

SEC source: 0001562180-24-007249 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198,813

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $13.35 USD to $13.70 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 03, 2024 Filed Sep 4, 2024 21:51 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,414 $16.35 $23,118.90
Disclosure

SEC source: 0001562180-24-006636 · primarydocument.xml · nonDerivative · entry 2

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 200,367

F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F3 · balance_after: Includes 136,197 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
September 03, 2024 Filed Sep 4, 2024 21:51 UTC SI-BONE, Inc. SIBN · Entity 2501 GrantCommon Stock 3,019 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-006636 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 201,781

F1 · kind: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest on January 1, 2025, subject to the Reporting Person's continued service through the relevant vesting date.

Read SEC document
August 16, 2024 Filed Aug 20, 2024 23:53 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,155 $13.88 $16,033.25
Disclosure

SEC source: 0001562180-24-006414 · primarydocument.xml · nonDerivative · entry 2

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198,762

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $13.77 USD to $14.15 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote

F4 · balance_after: Includes 133,178 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
August 16, 2024 Filed Aug 20, 2024 23:53 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,263 $13.86 $17,504.42
Disclosure

SEC source: 0001562180-24-006414 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 199,917

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $13.77 USD to $14.13 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote

Read SEC document
July 02, 2024 Filed Jul 5, 2024 21:41 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,753 $12.91 $22,625.45
Disclosure

SEC source: 0001562180-24-005631 · primarydocument.xml · nonDerivative · entry 2

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201,180

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $12.725 USD to $12.98 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 · balance_after: Includes 138,180 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
July 02, 2024 Filed Jul 5, 2024 21:41 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,556 $12.90 $20,068.20
Disclosure

SEC source: 0001562180-24-005631 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 202,933

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $12.77 USD to $13.00 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 16, 2024 Filed May 18, 2024 00:06 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,166 $15.14 $17,648.23
Disclosure

SEC source: 0001562180-24-004173 · primarydocument.xml · nonDerivative · entry 2

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 204,489

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.05 USD to $15.21 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Included 1,414 shares acquired under the SI-BONE Employee Stock Purchase Plan on May 15, 2024.

F4 · balance_after: Includes 144,960 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
May 16, 2024 Filed May 18, 2024 00:06 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,275 $15.14 $19,305.67
Disclosure

SEC source: 0001562180-24-004173 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 204,241

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.05 USD to $15.21 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 23:59 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,285 $15.46 $19,866.49
Disclosure

SEC source: 0001562180-24-003311 · primarydocument.xml · nonDerivative · entry 2

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,516

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $15.37 USD to $15.57 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 · balance_after: Includes 149,963 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 23:59 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,140 $15.45 $17,607.30
Disclosure

SEC source: 0001562180-24-003311 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 206,801

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.39 USD to $15.51 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 21:20 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 2,282 $20.96 $47,819.31
Disclosure

SEC source: 0001562180-24-001536 · primarydocument.xml · nonDerivative · entry 4

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 207,941

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $20.52 USD to $21.52 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes 156,743 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 21:20 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 3,266 $20.96 $68,439.03
Disclosure

SEC source: 0001562180-24-001536 · primarydocument.xml · nonDerivative · entry 3

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 210,223

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $20.52 USD to $21.52 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 21:20 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 934 $20.96 $19,571.97
Disclosure

SEC source: 0001562180-24-001536 · primarydocument.xml · nonDerivative · entry 2

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 213,489

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $20.52 USD to $21.52 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 16, 2024 Filed Feb 21, 2024 21:20 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 854 $20.96 $17,895.57
Disclosure

SEC source: 0001562180-24-001536 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 214,423

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $20.52 USD to $21.52 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 05, 2024 Filed Jan 5, 2024 22:52 UTC SI-BONE, Inc. SIBN · Entity 2501 GrantCommon Stock 17,002 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-000311 · primarydocument.xml · nonDerivative · entry 2

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,277

F2 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest, if at all, over three years based on the Issuer's total shareholder return (TSR) as measured against the TSR of the company at the median of the range TSRs of a set of peer companies established by the Issuer as set forth in the grant.

F3 · balance_after: Includes 177,420 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 05, 2024 Filed Jan 5, 2024 22:52 UTC SI-BONE, Inc. SIBN · Entity 2501 GrantCommon Stock 51,007 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-000311 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198,275

F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest over four years beginning on January 1, 2024, and will be released in quarterly installments, subject to the Reporting Person's continued service through each relevant vesting date.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 23:06 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,470 $20.92 $30,758.28
Disclosure

SEC source: 0001562180-24-000267 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,268

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $20.63 USD to $21.24 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes 109,411 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
November 16, 2023 Filed Nov 20, 2023 23:43 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 828 $17.54 $14,525.69
Disclosure

SEC source: 0001562180-23-007804 · primarydocument.xml · nonDerivative · entry 2

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,738

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $17.16 USD to $17.88 USD; the price reported above reflects the weighted average sale price.The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes 113,004 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
November 16, 2023 Filed Nov 20, 2023 23:43 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 905 $17.63 $15,951.98
Disclosure

SEC source: 0001562180-23-007804 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,566

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $17.16 USD to $17.88 USD; the price reported above reflects the weighted average sale price.The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 02, 2023 Filed Oct 4, 2023 21:51 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,244 $21.15 $26,309.85
Disclosure

SEC source: 0001562180-23-007212 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,471

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $20.93 USD to $21.29 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes 118,006 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
August 16, 2023 Filed Aug 18, 2023 20:13 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 905 $20.94 $18,948.62
Disclosure

SEC source: 0001562180-23-006436 · primarydocument.xml · nonDerivative · entry 2

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151,715

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $20.75 USD to $21.13 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 · balance_after: Includes 121,598 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
August 16, 2023 Filed Aug 18, 2023 20:13 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 828 $21.03 $17,414.41
Disclosure

SEC source: 0001562180-23-006436 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,620

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $20.82 USD to $21.125 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 03, 2023 Filed Jul 5, 2023 22:13 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,244 $26.70 $33,218.78
Disclosure

SEC source: 0001562180-23-005729 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,448

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $26.62 USD to $26.93 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes 126,601 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 21:11 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 3,272 $28.00 $91,616.00
Disclosure

SEC source: 0001562180-23-005038 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 154,692

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2 · balance_after: Includes 130,194 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
May 16, 2023 Filed May 18, 2023 21:34 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,891 $24.39 $46,123.00
Disclosure

SEC source: 0001562180-23-004249 · primarydocument.xml · nonDerivative · entry 3

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 157,964

F4 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F5 · balance_after: Included 1,891 shares acquired under the SI-BONE Employee Stock Purchase Plan on May 15, 2023.

F6 · balance_after: Includes 130,194 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer'scommon stock

Read SEC document
May 16, 2023 Filed May 18, 2023 21:34 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 828 $24.46 $20,250.06
Disclosure

SEC source: 0001562180-23-004249 · primarydocument.xml · nonDerivative · entry 2

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 157,964

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $24.02 USD to $24.78 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 16, 2023 Filed May 18, 2023 21:34 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 905 $24.68 $22,332.32
Disclosure

SEC source: 0001562180-23-004249 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 158,792

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $24.14 USD to $24.83 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 22:46 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,229 $19.30 $23,719.09
Disclosure

SEC source: 0001562180-23-003454 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 159,697

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $19.15 to $19.53; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes 135,196 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
February 28, 2023 Filed Mar 2, 2023 23:44 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,986 $21.00 $41,706.00
Disclosure

SEC source: 0001562180-23-002188 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,926

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2 · balance_after: Includes 138,788 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer'scommon stock.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 21:08 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 1,546 $16.78 $25,948.84
Disclosure

SEC source: 0001562180-23-001492 · primarydocument.xml · nonDerivative · entry 3

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,912

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · balance_after: Includes 138,788 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 21:08 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 870 $16.80 $14,615.39
Disclosure

SEC source: 0001562180-23-001492 · primarydocument.xml · nonDerivative · entry 2

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,458

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 21:08 UTC SI-BONE, Inc. SIBN · Entity 2501 SaleCommon Stock 796 $16.93 $13,474.37
Disclosure

SEC source: 0001562180-23-001492 · primarydocument.xml · nonDerivative · entry 1

Maheshwari Anshul · CIK 0001853089 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,328

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.